
A disorder where breathing repeatedly stops during sleep because the brain doesn't send proper signals to the breathing muscles.
Central Sleep Apnea (CSA) is a less common form of sleep apnea that occurs when your brain doesn't send proper signals to the muscles that control breathing. Unlike obstructive sleep apnea, where there is a physical blockage of the airway, in central sleep apnea the airway is not blocked but the brain fails to signal the muscles to breathe. This results in no breathing effort for brief periods during sleep. CSA can occur on its own or be associated with other conditions, particularly heart failure, stroke, or opioid use.
CSA is less common than obstructive sleep apnea, affecting less than 1% of the general population. However, it is much more prevalent in certain groups: up to 30-50% of patients with heart failure have CSA, and it frequently occurs in patients using long-term opioid medications.
CSA occurs when the brain fails to transmit signals to breathing muscles. Common causes include heart failure (Cheyne-Stokes respiration), stroke or brain injury affecting the brainstem, high altitude exposure, opioid medication use, and idiopathic (unknown) causes. Medical conditions that affect the brainstem, such as Parkinson's disease or multiple system atrophy, can also cause CSA.
Occurs without any identifiable cause (idiopathic). The brain intermittently fails to signal breathing during sleep.
A pattern of gradually increasing then decreasing breathing effort, followed by a central apnea. Common in heart failure and stroke patients.
Central apneas that develop or persist when obstructive events are treated with CPAP. Previously called complex sleep apnea.
Central apneas occurring at high altitudes due to changes in oxygen and carbon dioxide levels affecting breathing control.
CSA caused by chronic use of opioid medications, which depress the respiratory centers in the brain.
Unlike OSA, these pauses may not be accompanied by snoring or gasping. A bed partner may notice periods where breathing simply stops.
You may wake up suddenly feeling short of breath or with a sensation that you need to catch your breath.
Repeated awakenings throughout the night prevent restful sleep, leading to excessive tiredness during the day.
Low oxygen levels during sleep can cause headaches upon waking.
Sleep fragmentation impairs cognitive function, affecting memory, attention, and decision-making.
Poor sleep quality can lead to irritability, depression, or anxiety.
Difficulty staying asleep due to repeated arousals from apnea events.
If you answer yes to any of these questions, consider consulting a sleep specialist:
Diagnosis requires an overnight sleep study (polysomnography) to distinguish CSA from obstructive sleep apnea. The study measures brain activity, eye movements, muscle activity, heart rate, breathing effort, airflow, and blood oxygen levels.
The definitive test for CSA. It shows apnea events occurring without any breathing effort, distinguishing CSA from OSA where effort is present but airflow is blocked.
May be performed to check for underlying conditions such as heart failure, kidney function, or thyroid disorders that can contribute to CSA.
Echocardiogram and other heart tests may be done to assess for heart failure, a common cause of Cheyne-Stokes respiration pattern CSA.
MRI or CT scans may be ordered if a brain lesion or stroke is suspected as the cause of CSA.
Treatment focuses on addressing the underlying cause when possible and normalizing breathing during sleep. Options vary based on the specific type and cause of CSA.
Optimizing treatment for heart failure, reducing opioid dosages when possible, or addressing other underlying causes can significantly improve or resolve CSA.
A specialized device that monitors breathing and delivers variable pressure to normalize breathing patterns. Highly effective for many forms of CSA but contraindicated in patients with symptomatic heart failure with reduced ejection fraction.
Continuous positive airway pressure can be effective for some patients with CSA, particularly those with treatment-emergent CSA.
Bilevel positive airway pressure with a backup respiratory rate ensures minimum breaths per minute, useful when the brain fails to initiate breathing.
Nocturnal oxygen therapy can help maintain blood oxygen levels and may reduce the frequency of central apneas in some patients.
An implanted device (Remede System) that stimulates the phrenic nerve to contract the diaphragm, causing the patient to breathe. Approved for moderate to severe CSA.
Search our directory for sleep clinics that specialize in treating central sleep apnea (csa).
Search Clinics